SynthesisFrontiers in oncology2025

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.

Hua Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.